nach oben

Erschienen in:

01.02.2010 | Original paper

Intentional weight loss and risk of lymphohematopoietic cancers

verfasst von: Anneclaire J. De Roos, Cornelia M. Ulrich, Roberta M. Ray, Yasmin Mossavar-Rahmani, Carol A. Rosenberg, Bette J. Caan, Cynthia A. Thomson, Anne McTiernan, Andrea Z. LaCroix

Erschienen in: Cancer Causes & Control | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We hypothesized that intentional weight loss may be associated with development of lymphohematopoietic cancers, based on observations of immune suppression following weight loss in short-term studies.

Methods

At the baseline of the Women’s Health Initiative Observational Study (1994–1998), participants reported information about intentional weight loss episodes in the past 20 years. We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) among 81,219 women for associations between past intentional weight loss and risk of developing non-Hodgkin lymphoma (NHL), leukemia, and multiple myeloma during an average 9.9 years of follow-up.

Results

The risk of NHL was associated with having lost a large maximum amount of weight (≥50 pounds, HR = 1.68, 95% CI 1.13–2.50). NHL risk also varied by the frequency of intentional weight loss; women had increased risk if they lost 50 pounds or more ≥3 times (HR = 1.97, 95% CI 0.93–4.16; p trend by frequency = 0.09) or 20–49 pounds ≥3 times (HR = 1.55, 95% CI 1.00–2.40; p trend = 0.05), but there was no risk associated with smaller amounts of weight loss (10–19 pounds ≥3 times, HR = 0.78, 95% CI 0.46–1.33). These associations persisted with adjustment for body mass index at different ages. We observed non-significant associations of similar magnitude for multiple myeloma, but past intentional weight loss episodes were not associated with leukemia.

Conclusion

Further assessment of intentional weight loss as a possible risk factor for lymphomas may provide insight into the etiology of these cancers.

Nur mit Berechtigung zugänglich

Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L (2003) Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138(1):24–32PubMed

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625–1638CrossRefPubMed

Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB (2003) Years of life lost due to obesity. JAMA 289(2):187–193CrossRefPubMed

Seidell JC, Verschuren WM, van Leer EM, Kromhout D (1996) Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med 156(9):958–963CrossRefPubMed

Anderson JW, Konz EC (2001) Obesity and disease management: effects of weight loss on comorbid conditions. Obes Res 9(Suppl 4):326S–334SCrossRefPubMed

Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351(26):2683–2693CrossRefPubMed

Manco M, Fernandez-Real JM, Valera-Mora ME et al (2007) Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon? Diabetes Care 30(6):1494–1500CrossRefPubMed

O’Brien KD, Brehm BJ, Seeley RJ et al (2005) Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 90(4):2244–2249CrossRefPubMed

Buchwald H, Varco RL, Matts JP et al (1990) Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 323(14):946–955PubMed

10.

Manco M, Fernandez-Real JM, Equitani F et al (2007) Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 92(2):483–490CrossRefPubMed

11.

Fujimoto WY, Jablonski KA, Bray GA et al (2007) Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes 56(6):1680–1685CrossRefPubMed

12.

Torgerson JS, Sjostrom L (2001) The Swedish Obese Subjects (SOS) study—rationale and results. Int J Obes Relat Metab Disord 25(Suppl 1):S2–S4CrossRefPubMed

13.

Adams TD, Gress RE, Smith SC et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357(8):753–761CrossRefPubMed

14.

Scanga CB, Verde TJ, Paolone AM, Andersen RE, Wadden TA (1998) Effects of weight loss and exercise training on natural killer cell activity in obese women. Med Sci Sports Exerc 30(12):1666–1671CrossRefPubMed

15.

Nieman DC, Nehlsen-Cannarella SI, Henson DA et al (1996) Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord 20(4):353–360PubMed

16.

Kelley DS, Daudu PA, Branch LB, Johnson HL, Taylor PC, Mackey B (1994) Energy restriction decreases number of circulating natural killer cells and serum levels of immunoglobulins in overweight women. Eur J Clin Nutr 48(1):9–18PubMed

17.

Shade ED, Ulrich CM, Wener MH et al (2004) Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity in postmenopausal women: possible long-term immune effects. J Am Diet Assoc 104(6):903–912CrossRefPubMed

18.

Grulich AE, Wan X, Law MG, Coates M, Kaldor JM (1999) Risk of cancer in people with AIDS. AIDS 13(7):839–843CrossRefPubMed

19.

Fordyce EJ, Wang Z, Kahn AR et al (2000) Risk of cancer among women with AIDS in New York City. AIDS Public Policy J 15(3–4):95–104PubMed

20.

Schwartz RS (2001) Immunodeficiency, immunosuppression, and susceptibility to neoplasms. J Natl Cancer Inst Monogr 28:5–9PubMed

21.

Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 159(3):259–268CrossRefPubMed

22.

Chiu BC, Gapstur SM, Greenland P, Wang R, Dyer A (2006) Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer. Cancer Epidemiol Biomarkers Prev 15(12):2348–2354CrossRefPubMed

23.

Oh SW, Yoon YS, Shin SA (2005) Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23(21):4742–4754CrossRefPubMed

24.

Willett EV, Skibola CF, Adamson P et al (2005) Non-Hodgkin’s lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer 93(7):811–816CrossRefPubMed

25.

Blair CK, Cerhan JR, Folsom AR, Ross JA (2005) Anthropometric characteristics and risk of multiple myeloma. Epidemiology 16(5):691–694CrossRefPubMed

26.

Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr (2004) Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15(1):35–43CrossRefPubMed

27.

Friedman GD, Herrinton LJ (1994) Obesity and multiple myeloma. Cancer Causes Control 5(5):479–483CrossRefPubMed

28.

Brown LM, Gridley G, Pottern LM et al (2001) Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States. Cancer Causes Control 12:117–125CrossRefPubMed

29.

Birmann BM, Giovannucci E, Rosner B, Anderson KC, Colditz GA (2007) Body mass index, physical activity, and risk of multiple myeloma. Cancer Epidemiol Biomarkers Prev 16(7):1474–1478CrossRefPubMed

30.

Cozen W, Gebregziabher M, Conti DV et al (2006) Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma. Cancer Epidemiol Biomarkers Prev 15(11):2285–2291CrossRefPubMed

31.

Field AE, Manson JE, Taylor CB, Willett WC, Colditz GA (2004) Association of weight change, weight control practices, and weight cycling among women in the Nurses’ Health Study II. Int J Obes Relat Metab Disord 28(9):1134–1142CrossRefPubMed

32.

Kroke A, Liese AD, Schulz M et al (2002) Recent weight changes and weight cycling as predictors of subsequent two year weight change in a middle-aged cohort. Int J Obes Relat Metab Disord 26(3):403–409CrossRefPubMed

33.

Van Wye G, Dubin JA, Blair SN, Di Pietro L (2007) Weight cycling and 6-year weight change in healthy adults: The Aerobics Center Longitudinal Study. Obesity (Silver Spring) 15(3):731–739CrossRef

34.

The Women’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19(1):61–109

35.

Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003) The Women’s Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13(9 Suppl):S107–S121CrossRefPubMed

36.

Curb JD, McTiernan A, Heckbert SR et al (2003) Outcomes ascertainment and adjudication methods in the Women’s Health Initiative. Ann Epidemiol 13(9 Suppl):S122–S128CrossRefPubMed

37.

WHO Expert Committee on Physical Status: The Use and Interpretation of Anthropometry (1995) Report of a WHO Expert Committee. WHO Technical Report Series; 854. World Health Organization, Geneva, Switzerland

38.

Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (eds) (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva

39.

Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107(1):265–276CrossRefPubMed

40.

Morton LM, Turner JJ, Cerhan JR et al (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110(2):695–708CrossRefPubMed

41.

Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286(10):1195–1200CrossRefPubMed

42.

Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 22(1):39–47CrossRefPubMed

43.

Hjartaker A, Laake P, Lund E (2001) Body mass index and weight change attempts among adult women. The Norwegian Women and Cancer Study. Eur J Public Health 11(2):141–146CrossRefPubMed

44.

Serdula MK, Mokdad AH, Williamson DF, Galuska DA, Mendlein JM, Heath GW (1999) Prevalence of attempting weight loss and strategies for controlling weight. JAMA 282(14):1353–1358CrossRefPubMed

45.

Levy AS, Heaton AW (1993) Weight control practices of U.S. adults trying to lose weight. Ann Intern Med 119(7 Pt 2):661–666PubMed

46.

McGuire MT, Wing RR, Hill JO (1999) The prevalence of weight loss maintenance among American adults. Int J Obes Relat Metab Disord 23(12):1314–1319CrossRefPubMed

47.

Wing RR, Hill JO (2001) Successful weight loss maintenance. Annu Rev Nutr 21:323–341CrossRefPubMed

48.

Sjostrom CD, Peltonen M, Wedel H, Sjostrom L (2000) Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 36(1):20–25PubMed

49.

Alexander DD, Mink PJ, Adami HO et al (2007) The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12):1–39CrossRefPubMed

50.

Chang ET, Hjalgrim H, Smedby KE et al (2005) Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 97(3):210–218PubMedCrossRef

51.

Cerhan JR, Janney CA, Vachon CM et al (2002) Anthropometric characteristics, physical activity, and risk of non-Hodgkin’s lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 156(6):527–535CrossRefPubMed

52.

Cerhan JR, Bernstein L, Severson RK et al (2005) Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control 16(10):1203–1214CrossRefPubMed

53.

Britton JA, Khan AE, Rohrmann S et al (2008) Anthropometric characteristics and non-Hodgkin’s lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 93(11):1666–1677CrossRefPubMed

54.

Larsson SC, Wolk A (2007) Obesity and risk of non-Hodgkin’s lymphoma: a meta-analysis. Int J Cancer 121(7):1564–1570CrossRefPubMed

55.

Willett EV, Morton LM, Hartge P et al (2008) Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 122(9):2062–2070CrossRefPubMed

56.

Larsson SC, Wolk A (2008) Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer 122(6):1418–1421CrossRefPubMed

57.

Alexander DD, Mink PJ, Adami HO et al (2007) Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12):40–61CrossRefPubMed

58.

Nieman DC, Nehlsen-Cannarella SL, Henson DA et al (1998) Immune response to exercise training and/or energy restriction in obese women. Med Sci Sports Exerc 30(5):679–686CrossRefPubMed

59.

Plat J, Jellema A, Ramakers J, Mensink RP (2007) Weight loss, but not fish oil consumption, improves fasting and postprandial serum lipids, markers of endothelial function, and inflammatory signatures in moderately obese men. J Nutr 137(12):2635–2640PubMed

60.

Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591CrossRefPubMed

61.

Khan M, Mori M, Fujino Y et al (2006) Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7(2):253–259PubMed

62.

Fortuny J, Benavente Y, Bosch R, Garcia-Villanueva M, de Sevilla AF, de Sanjose S (2005) Type 2 diabetes mellitus, its treatment and risk for lymphoma. Eur J Cancer 41(12):1782–1787CrossRefPubMed

63.

Lee JS, Visser M, Tylavsky FA et al. (2009) Weight Loss and Regain and Effects on Body Composition: The Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci (Epub ahead of print)

64.

Henderson DC, Fan X, Sharma B et al (2009) Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine. J Psychiatr Pract 15(4):251–261CrossRefPubMed

65.

Chen CN, Chuang LM, Wu YT (2008) Clinical measures of physical fitness predict insulin resistance in people at risk for diabetes. Phys Ther 88(11):1355–1364PubMed

Titel: Intentional weight loss and risk of lymphohematopoietic cancers
verfasst von: Anneclaire J. De Roos
Cornelia M. Ulrich
Roberta M. Ray
Yasmin Mossavar-Rahmani
Carol A. Rosenberg
Bette J. Caan
Cynthia A. Thomson
Anne McTiernan
Andrea Z. LaCroix
Publikationsdatum: 01.02.2010
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 2/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-009-9453-5

Springer Medizin

Intentional weight loss and risk of lymphohematopoietic cancers